Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Neupro submitted for approval in U.S., Europe for Parkinson's disease

Oct. 7, 2004

Roche scientists describe new selective GlyT-1 inhibitors

Oct. 7, 2004

Phase III trial of Ikomio for ALS fails to show survival benefit

Oct. 6, 2004

Three series of GSK-3beta inhibitors in early development at Sanofi-Synthelabo

Oct. 6, 2004

New pharmacokinetic data for ramelteon presented at the ACCP meeting

Oct. 6, 2004

Three series of COX-2 inhibitors designed at Almirall Prodesfarma

Oct. 6, 2004

Abilify approved for acute bipolar mania

Oct. 5, 2004

New nAChR ligands and their use described by Aventis and Targacept

Oct. 5, 2004

BTG enters into agreements in field of sleep apnea

Oct. 4, 2004

Favorable review for Neurologix's protocol for epilepsy gene therapy study

Oct. 4, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...